- Home
- FCRS vs VOR Comparison
FCRS vs VOR Comparison
Compare FCRS & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
N/A
Current Price
$16.03
Company Overview
Basic Information| Metric | FCRS | VOR |
|---|---|---|
| Founded | 2025 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 360.8M | 562.6M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | FCRS | VOR |
|---|---|---|
| Price | $10.05 | $16.03 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $64.78 |
| AVG Volume (30 Days) | 216.6K | ★ 618.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 2.86 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.03 | $0.13 |
| 52 Week High | $10.92 | $49.95 |
Technical Indicators
Market Signals| Indicator | FCRS | VOR |
|---|---|---|
| Relative Strength Index (RSI) | 37.59 | 60.22 |
| Support Level | N/A | $11.27 |
| Resistance Level | $10.34 | $16.95 |
| Average True Range (ATR) | 0.02 | 1.14 |
| MACD | 0.00 | 0.09 |
| Stochastic Oscillator | 25.00 | 75.99 |
Price Performance
Historical Comparison FCRS
VOR
About FCRS FutureCrest Acquisition Corp. Class A Ordinary Shares
FutureCrest Acquisition Corp is a blank check company.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.